Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
QUIA PHARMA AB (publ)
AB
Bankrupt
Org 5566580196
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2004 · 22 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
QUIA PHARMA AB (publ)
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
EBITDA
SEK millions
0M
-1M
-2M
-4M
-5M
2020: -4M
-4M
2020
2021: -3M (+25% vs 2020)
-3M
+25%
2021
2022: -2M (+33% vs 2021)
-2M
+33%
2022
2023: -3M (-50% vs 2022)
-3M
-50%
2023
2024: -4M (-33% vs 2023)
-4M
-33%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
0
0
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
−3 625
−2 524
−2 288
−2 849
−4 000
Depreciation & amort.
−19 450
−0
−0
−0
−0
EBIT
−23 075
−2 524
−2 288
−2 849
−4 000
Net financials
−11 546
−38 006
−26 340
−17 449
−23 000
Profit before tax
−34 621
−40 530
−28 628
−20 298
−26 000
Tax
−0
−0
−0
−0
−0
Net profit
−34 621
−40 530
−28 628
−20 298
−26 000
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
14 410
38 420
45 382
52 599
45 000
Equity
11 904
16 493
27 662
33 812
34 000
Long-term debt
0
0
15 151
16 651
0
Short-term debt
2 506
21 927
2 569
2 135
11 000
Total debt
2 506
21 927
17 720
18 786
11 000
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2020
2024
Equity ratio
82,6 %
This company
38,2 %
Market median
This company
Market median
116% above market
2020
2024
Return on equity
−290,8 %
This company
18,4 %
Market median
This company
Market median
>999% below market
2020
2024
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2020
2024
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2020
2024
Debt / equity
0,21×
This company
0,62×
Market median
This company
Market median
66% below market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on QUIA PHARMA AB (publ)
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
